Williams Jones Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Sell |
978
-95
| -9% | -$49.9K | 0.01% | 345 |
|
|
2025
Q1 | $681K | Sell |
1,073
-25
| -2% | -$15.9K | 0.01% | 291 |
|
|
2024
Q4 | $782K | Sell |
1,098
-715
| -39% | -$509K | 0.01% | 274 |
|
|
2024
Q3 | $1.91M | Sell |
1,813
-2
| -0.1% | -$2.1K | 0.02% | 199 |
|
|
2024
Q2 | $1.91M | Buy |
1,815
+36
| +2% | +$37.8K | 0.02% | 195 |
|
|
2024
Q1 | $1.71M | Buy |
1,779
+58
| +3% | +$55.8K | 0.02% | 210 |
|
|
2023
Q4 | $1.51M | Sell |
1,721
-85
| -5% | -$74.7K | 0.02% | 220 |
|
|
2023
Q3 | $1.49M | Buy |
1,806
+70
| +4% | +$57.6K | 0.02% | 215 |
|
|
2023
Q2 | $1.25M | Hold |
1,736
| – | – | 0.02% | 231 |
|
|
2023
Q1 | $1.43M | Hold |
1,736
| – | – | 0.02% | 231 |
|
|
2022
Q4 | $1.25M | Hold |
1,736
| – | – | 0.02% | 241 |
|
|
2022
Q3 | $1.2M | Hold |
1,736
| – | – | 0.02% | 244 |
|
|
2022
Q2 | $1.03M | Buy |
1,736
+15
| +0.9% | +$8.87K | 0.02% | 270 |
|
|
2022
Q1 | $1.2M | Sell |
1,721
-1
| -0.1% | -$698 | 0.02% | 248 |
|
|
2021
Q4 | $1.09M | Buy |
1,722
+42
| +3% | +$26.5K | 0.01% | 251 |
|
|
2021
Q3 | $1.02M | Sell |
1,680
-12
| -0.7% | -$7.26K | 0.01% | 246 |
|
|
2021
Q2 | $945K | Sell |
1,692
-192
| -10% | -$107K | 0.01% | 257 |
|
|
2021
Q1 | $891K | Buy |
1,884
+39
| +2% | +$18.4K | 0.01% | 255 |
|
|
2020
Q4 | $891K | Buy |
1,845
+380
| +26% | +$184K | 0.01% | 233 |
|
|
2020
Q3 | $820K | Buy |
1,465
+256
| +21% | +$143K | 0.02% | 218 |
|
|
2020
Q2 | $754K | Buy |
+1,209
| New | +$754K | 0.02% | 220 |
|